Sergio Iadevaia

648 total citations
19 papers, 496 citations indexed

About

Sergio Iadevaia is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Sergio Iadevaia has authored 19 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Sergio Iadevaia's work include PI3K/AKT/mTOR signaling in cancer (5 papers), Gene Regulatory Network Analysis (4 papers) and Growth Hormone and Insulin-like Growth Factors (3 papers). Sergio Iadevaia is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (5 papers), Gene Regulatory Network Analysis (4 papers) and Growth Hormone and Insulin-like Growth Factors (3 papers). Sergio Iadevaia collaborates with scholars based in United States, Norway and Italy. Sergio Iadevaia's co-authors include Prahlad T. Ram, Gordon B. Mills, Yiling Lu, Fabiana C. Morales, Alexey A. Lugovskoy, Brian D. Harms, Jeffrey D. Kearns, Birgit Schoeberl, Victoria Rimkunas and Nikos V. Mantzaris and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Sergio Iadevaia

18 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sergio Iadevaia United States 9 330 204 140 77 53 19 496
Samar Alanazi United States 8 347 1.1× 271 1.3× 101 0.7× 66 0.9× 29 0.5× 13 575
Yihua Qiu United States 7 523 1.6× 144 0.7× 74 0.5× 95 1.2× 20 0.4× 9 657
Curtis H. Kugel United States 8 382 1.2× 239 1.2× 42 0.3× 57 0.7× 54 1.0× 8 461
Pegram United States 2 220 0.7× 355 1.7× 140 1.0× 98 1.3× 14 0.3× 2 507
Diana Spiegelberg Sweden 14 308 0.9× 279 1.4× 120 0.9× 93 1.2× 9 0.2× 31 555
Mattia Cremona Ireland 12 323 1.0× 287 1.4× 43 0.3× 147 1.9× 18 0.3× 31 672
Jane Arboleda United States 5 414 1.3× 575 2.8× 251 1.8× 157 2.0× 20 0.4× 7 859
Nara De Matos Granja-Ingram United States 3 364 1.1× 404 2.0× 215 1.5× 70 0.9× 16 0.3× 3 613
Tom Januario United States 5 463 1.4× 262 1.3× 39 0.3× 126 1.6× 20 0.4× 8 628
Hannah Linden United States 5 300 0.9× 220 1.1× 53 0.4× 58 0.8× 35 0.7× 12 457

Countries citing papers authored by Sergio Iadevaia

Since Specialization
Citations

This map shows the geographic impact of Sergio Iadevaia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio Iadevaia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio Iadevaia more than expected).

Fields of papers citing papers by Sergio Iadevaia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergio Iadevaia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio Iadevaia. The network helps show where Sergio Iadevaia may publish in the future.

Co-authorship network of co-authors of Sergio Iadevaia

This figure shows the co-authorship network connecting the top 25 collaborators of Sergio Iadevaia. A scholar is included among the top collaborators of Sergio Iadevaia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergio Iadevaia. Sergio Iadevaia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Guzy, Serge, Tomoki Yoneyama, Sergio Iadevaia, et al.. (2025). Establishment of a Biomarker‐Directed Clinical Endpoint Model for Early‐Stage Parkinson's Disease Patients. Clinical Pharmacology & Therapeutics. 117(5). 1460–1469. 2 indexed citations
2.
Gnagnarella, Patrizia, Aurora Gaeta, Davide Serrano, et al.. (2025). Coffee and tea intake and survival of cancer patients: a systematic review and meta-analysis. Cancer Causes & Control. 36(11). 1463–1475.
3.
Linninger, Andreas A., Dipak Barua, Yaming Hang, Sergio Iadevaia, & Majid Vakilynejad. (2023). A mechanistic pharmacokinetic model for intrathecal administration of antisense oligonucleotides. Frontiers in Physiology. 14. 1130925–1130925. 8 indexed citations
4.
Curley, Michael D., Sergio Iadevaia, Victoria Rimkunas, et al.. (2019). Dual targeting of IGF-1R and ErbB3 as a potential therapeutic regimen for ovarian cancer. Scientific Reports. 9(1). 16832–16832. 17 indexed citations
5.
Pace, Emily A., Sharlene Adams, Michael D. Curley, et al.. (2018). Dual Inhibition of IGF-1R and ErbB3 Enhances the Activity of Gemcitabine and Nab-Paclitaxel in Preclinical Models of Pancreatic Cancer. Clinical Cancer Research. 24(12). 2873–2885. 44 indexed citations
6.
Pace, Emily, Sharlene Adams, Michael Curley, et al.. (2015). Effect of MM-141 on gemcitabine and nab-paclitaxel potentiation in preclinical models of pancreatic cancer through induction of IGF-1R and ErbB3 degradation.. Journal of Clinical Oncology. 33(3_suppl). 289–289. 4 indexed citations
7.
Adams, Sharlene, Michael D. Curley, Sergio Iadevaia, et al.. (2015). Abstract A89: Istiratumab (MM-141), a bispecific antibody co-targeting IGF-1R and ErbB3, potentiates the activity of immune checkpoint inhibitors. Molecular Cancer Therapeutics. 14(12_Supplement_2). A89–A89. 2 indexed citations
8.
Iadevaia, Sergio, Luay Nakhleh, Robert Azencott, & Prahlad T. Ram. (2014). Mapping Network Motif Tunability and Robustness in the Design of Synthetic Signaling Circuits. PLoS ONE. 9(3). e91743–e91743. 4 indexed citations
9.
Krohn, Marit, Sergio Iadevaia, Alexandr Kristian, et al.. (2013). Proteomic Characterization of Breast Cancer Xenografts Identifies Early and Late Bevacizumab-Induced Responses and Predicts Effective Drug Combinations. Clinical Cancer Research. 20(2). 404–412. 28 indexed citations
10.
Fitzgerald, Jonathan B., Bryan W. Johnson, Jason Baum, et al.. (2013). MM-141, an IGF-IR– and ErbB3-Directed Bispecific Antibody, Overcomes Network Adaptations That Limit Activity of IGF-IR Inhibitors. Molecular Cancer Therapeutics. 13(2). 410–425. 87 indexed citations
11.
Harms, Brian D., Jeffrey D. Kearns, Sergio Iadevaia, & Alexey A. Lugovskoy. (2013). Understanding the role of cross-arm binding efficiency in the activity of monoclonal and multispecific therapeutic antibodies. Methods. 65(1). 95–104. 46 indexed citations
12.
Adams, Sharlene, Jason Baum, Victoria Rimkunas, et al.. (2013). Abstract C169: MM-141, a bispecific antibody inhibitor of PI3K/AKT/mTOR, attenuates tumor growth and potentiates everolimus in mouse models of anti-hormonal therapy-resistant ER/PR+ breast cancer.. Molecular Cancer Therapeutics. 12(11_Supplement). C169–C169. 1 indexed citations
13.
Baum, Jason, Bryan W. Johnson, Sharlene Adams, et al.. (2012). 316 MM-141, a Novel Bispecific Antibody Co-targeting IGF-1R and ErbB3, Inhibits PI3K/Akt/mTOR Pro-survival Signaling in Preclinical Cancer Models. European Journal of Cancer. 48. 97–97. 2 indexed citations
14.
Lu, Yiling, Mathias Müller, David M. Smith, et al.. (2011). Kinome siRNA-phosphoproteomic screen identifies networks regulating AKT signaling. Oncogene. 30(45). 4567–4577. 57 indexed citations
15.
Iadevaia, Sergio & Prahlad T. Ram. (2011). Abstract 4920: Integrative identification of stochastically activated signaling sub-networks in individual cancer cells. Cancer Research. 71(8_Supplement). 4920–4920. 12 indexed citations
16.
Iadevaia, Sergio, Yiling Lu, Fabiana C. Morales, Gordon B. Mills, & Prahlad T. Ram. (2010). Identification of Optimal Drug Combinations Targeting Cellular Networks: Integrating Phospho-Proteomics and Computational Network Analysis. Cancer Research. 70(17). 6704–6714. 164 indexed citations
17.
Iadevaia, Sergio, et al.. (2009). Environmentally-modulated changes in fluorescence distribution in cells with oscillatory genetic network dynamics. Journal of Biotechnology. 140(3-4). 203–217. 4 indexed citations
18.
Iadevaia, Sergio & Nikos V. Mantzaris. (2006). Synthesis of PHBV block copolymers driven by an oscillatory genetic network. Journal of Biotechnology. 128(3). 615–637. 3 indexed citations
19.
Iadevaia, Sergio & Nikos V. Mantzaris. (2005). Genetic network driven control of PHBV copolymer composition. Journal of Biotechnology. 122(1). 99–121. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samar Alanazi Breakdown of academic impact, for papers by Yihua Qiu Breakdown of academic impact, for papers by Curtis H. Kugel Breakdown of academic impact, for papers by Pegram Breakdown of academic impact, for papers by Diana Spiegelberg Breakdown of academic impact, for papers by Mattia Cremona Breakdown of academic impact, for papers by Jane Arboleda Breakdown of academic impact, for papers by Nara De Matos Granja-Ingram Breakdown of academic impact, for papers by Tom Januario Breakdown of academic impact, for papers by Hannah Linden
Rankless by CCL
2026